Hospital
Hernando Hma LLC
Hernando Hma LLC was paid $4.23M by Medicaid between Jan 2018 and Oct 2023, across 102 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoHERNANDO HMA LLC
BROOKSVILLE, FL 34601
BROOKSVILLE, FL 34601
33aNPI1588695514assigned 07/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.23M
24GClaims186,011
24DCodes billed102
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#89 of 163
Median peer was paid$4.77M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,197 | $163K | |
| 2019 | 39,109 | $505K | |
| 2020 | 34,317 | $428K | |
| 2021 | 42,162 | $967K | |
| 2022 | 39,735 | $1.47M | |
| 2023 | 18,491 | $696K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 14,112 | 12,413 | $1.23M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 9,556 | 8,053 | $577K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10% | 3,854 | 3,542 | $434K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.0% | 1,669 | 1,503 | $296K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.9% | 2,948 | 2,329 | $251K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.9% | 3,859 | 3,094 | $249K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.3% | 1,086 | 936 | $183K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.0% | 2,388 | 2,206 | $170K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.9% | 3,236 | 2,685 | $124K |
| 36415 | Collection of venous blood by venipuncture | 2.9% | 11,567 | 8,043 | $122K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.3% | 1,666 | 1,473 | $96K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 992 | 756 | $40K |
90 more codes
| G0378 | Hospital observation service, per hour | <1% | 1,374 | $39K |
| 80053 | Comprehensive metabolic panel | <1% | 11,723 | $38K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,089 | $34K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,393 | $32K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 123 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,838 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,111 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,287 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,273 | $14K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,866 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,792 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,514 | $12K |
| 81001 | <1% | 6,241 | $11K | |
| 85610 | <1% | 4,636 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,366 | $9K |
| 73630 | <1% | 319 | $8K | |
| 81003 | <1% | 1,654 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 174 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,725 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,906 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,265 | $7K |
| 84484 | <1% | 4,179 | $6K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 96 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 681 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,689 | $6K |
| 85730 | <1% | 4,239 | $5K | |
| 83735 | <1% | 5,183 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,933 | $4K |
| 73564 | <1% | 197 | $4K | |
| 73130 | <1% | 142 | $4K | |
| 73610 | <1% | 168 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,378 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,237 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,622 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 268 | $2K |
| 85027 | <1% | 1,052 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,344 | $2K |
| 73030 | <1% | 186 | $2K | |
| 83690 | <1% | 3,292 | $2K | |
| 87428 | <1% | 1,103 | $1K | |
| 82962 | <1% | 879 | $1K | |
| 96376 | <1% | 690 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 797 | $1K |
| 82550 | <1% | 1,588 | $1K | |
| 83880 | <1% | 1,446 | $1K | |
| 72131 | <1% | 14 | $1K | |
| 84703 | <1% | 423 | $820.78 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,095 | $818.69 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 30 | $752.06 |
| 93971 | <1% | 45 | $493.46 | |
| 87040 | <1% | 575 | $364.26 | |
| 85379 | <1% | 865 | $352.32 | |
| 82150 | <1% | 472 | $351.16 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,070 | $350.81 |
| 76830 | Ultrasound, transvaginal | <1% | 16 | $345.74 |
| 87186 | <1% | 585 | $274.18 | |
| 87807 | <1% | 512 | $268.47 | |
| 82553 | <1% | 938 | $234.96 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 439 | $181.09 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 41 | $171.46 |
| 86901 | <1% | 29 | $141.41 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 333 | $113.91 |
| 86140 | <1% | 60 | $113.85 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 156 | $113.45 |
| 87210 | <1% | 12 | $110.22 | |
| 80061 | Lipid panel | <1% | 342 | $106.30 |
| 82077 | <1% | 556 | $97.89 | |
| 81025 | <1% | 1,100 | $52.04 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 146 | $48.53 |
| 86900 | <1% | 14 | $33.33 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 41 | $27.84 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 24 | $25.00 |
| 87077 | <1% | 412 | $14.15 | |
| 94760 | <1% | 560 | $1.74 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 97 | $1.74 |
| 83605 | 0% | 266 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 337 | $0.00 |
| 87081 | 0% | 834 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 153 | $0.00 |
| 87430 | 0% | 966 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 33 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 40 | $0.00 |
| 83615 | 0% | 14 | $0.00 | |
| 87070 | 0% | 14 | $0.00 | |
| 87147 | 0% | 18 | $0.00 | |
| 85651 | 0% | 18 | $0.00 | |
| 80143 | 0% | 142 | $0.00 | |
| 84702 | 0% | 62 | $0.00 | |
| 80179 | 0% | 109 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.